Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan or 131I-Tositumomab

Sébastien Baechler, Robert F. Hobbs, Heather A. Jacene, François O. Bochud, Richard L. Wahl and George Sgouros
Journal of Nuclear Medicine December 2010, 51 (12) 1878-1884; DOI: https://doi.org/10.2967/jnumed.110.079947
Sébastien Baechler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert F. Hobbs
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather A. Jacene
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François O. Bochud
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Wahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Sgouros
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 51 no. 12 1878-1884
DOI 
https://doi.org/10.2967/jnumed.110.079947
PubMed 
21098795

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 4, 2010
  • Accepted for publication September 8, 2010
  • Published online November 23, 2010.

Copyright & Usage 
© 2010 by Society of Nuclear Medicine

Author Information

  1. Sébastien Baechler1,2,
  2. Robert F. Hobbs2,
  3. Heather A. Jacene2,
  4. François O. Bochud1,
  5. Richard L. Wahl2 and
  6. George Sgouros2
  1. 1Institute of Radiation Physics, University Hospital Center and University of Lausanne, Lausanne, Switzerland; and
  2. 2Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland
  1. For correspondence or reprints contact: Sébastien Baechler, Institute of Radiation Physics, University Hospital Center of Lausanne (CHUV), Grand-Pré 1, 1007 Lausanne, Switzerland. E-mail: sebastien.baechler{at}chuv.ch
View Full Text

Statistics from Altmetric.com

Cited By...

  • 30 Citations
  • 29 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A bone marrow toxicity model for223Ra alpha-emitter radiopharmaceutical therapy
    Robert F Hobbs, Hong Song, Christopher J Watchman, Wesley E Bolch, Anne-Kirsti Aksnes, Thomas Ramdahl, Glenn D Flux, George Sgouros
    Physics in Medicine and Biology 2012 57 10
  • ICRU REPORT 96, Dosimetry-Guided Radiopharmaceutical Therapy
    George Sgouros, Wesley E. Bolch, Arturo Chiti, Yuni K. Dewaraja, Dimitris Emfietzoglou, Robert F. Hobbs, Mark Konijnenberg, Katarina Sjögreen-Gleisner, Lidia Strigari, Tzu-Chen Yen, Roger W. Howell
    Journal of the ICRU 2021 21 1
  • Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer
    Aaron M. LeBeau, Sai Duriseti, Stephanie T. Murphy, Francois Pepin, Byron Hann, Joe W. Gray, Henry F. VanBrocklin, Charles S. Craik
    Cancer Research 2013 73 7
  • Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
    Paola A. Erba, Martina Sollini, Enrico Orciuolo, Claudio Traino, Mario Petrini, Giovanni Paganelli, Emilio Bombardieri, Chiara Grana, Leonardo Giovannoni, Dario Neri, Hans D. Menssen, Giuliano Mariani
    Journal of Nuclear Medicine 2012 53 6
  • Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
    Richard L. Wahl, George Sgouros, Amir Iravani, Heather Jacene, Daniel Pryma, Babak Saboury, Jacek Capala, Stephen A. Graves
    Journal of Nuclear Medicine 2021 62 Supplement 3
  • Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 Imaging
    Alexander B. Stillebroer, Catharina M.L. Zegers, Otto C. Boerman, Egbert Oosterwijk, Peter F.A. Mulders, Joseph A. O'Donoghue, Eric P. Visser, Wim J.G. Oyen
    Journal of Nuclear Medicine 2012 53 1
  • Imaging a functional tumorigenic biomarker in the transformed epithelium
    Aaron M. LeBeau, Minhee Lee, Stephanie T. Murphy, Byron C. Hann, Robert S. Warren, Romelyn Delos Santos, John Kurhanewicz, Samir M. Hanash, Henry F. VanBrocklin, Charles S. Craik
    Proceedings of the National Academy of Sciences 2013 110 1
  • The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia
    Brandon N. VanderVeen, E. Angela Murphy, James A. Carson
    Frontiers in Physiology 2020 11
  • The Acute Effects of 5 Fluorouracil on Skeletal Muscle Resident and Infiltrating Immune Cells in Mice
    Brandon N. VanderVeen, Alexander T. Sougiannis, Kandy T. Velazquez, James A. Carson, Daping Fan, E. Angela Murphy
    Frontiers in Physiology 2020 11
  • Improving the dose–myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP
    Massimiliano Pacilio, Guido Ventroni, Chiara Basile, Pasquale Ialongo, Domenico Becci, Lucio Mango
    European Journal of Nuclear Medicine and Molecular Imaging 2014 41 2

Article usage

Article usage: November 2010 to April 2025

AbstractFullPdf
Nov 2010911451
Dec 20105746121
Jan 2011355168
Feb 201183740
Mar 2011154038
Apr 2011123338
May 201172126
Jun 2011751834
Jul 2011471823
Aug 2011552728
Sep 2011733631
Oct 2011762737
Nov 2011772229
Dec 2011723632
Jan 2012502429
Feb 2012402220
Mar 2012573117
Apr 2012693420
May 2012473925
Jun 2012522021
Jul 2012342125
Aug 2012282211
Sep 2012622717
Oct 2012491827
Nov 2012372910
Dec 2012432620
Jan 2013522722
Feb 2013422813
Mar 2013162414
Apr 2013212419
May 2013462918
Jun 2013131720
Jul 201322811
Aug 2013321218
Sep 2013141012
Oct 2013182520
Nov 2013241225
Dec 201381417
Jan 2014112114
Feb 201412416
Mar 201412932
Apr 20146622
May 2014151216
Jun 20149915
Jul 2014181110
Aug 201421812
Sep 201425145
Oct 201429103
Nov 20141793
Dec 20142461
Jan 201513195
Feb 201522142
Mar 201539158
Apr 201521102
May 201532165
Jun 201518132
Jul 201517167
Aug 201521220
Sep 201518115
Oct 201517104
Nov 20152591
Dec 20153840
Jan 201642159
Feb 2016241211
Mar 201617523
Apr 201619811
May 201616127
Jun 201631232
Jul 201622121
Aug 20161594
Sep 201622141
Oct 201617113
Nov 201617124
Dec 2016973
Jan 20171160
Feb 20171261
Mar 2017983
Apr 20171261
May 2017940
Jun 2017960
Jul 2017380
Aug 2017780
Sep 2017581
Oct 2017971
Nov 20171363
Dec 2017642
Jan 2018452
Feb 20186122
Mar 2018493
Apr 20186141
May 201816120
Jun 20184120
Jul 20184161
Aug 2018550
Sep 20184213
Oct 20184212
Nov 20186231
Dec 20186290
Jan 20196271
Feb 20197266
Mar 201993614
Apr 20198245
May 2019732
Jun 2019601
Jul 20195126
Aug 2019675
Sep 2019200
Oct 2019612
Nov 2019514
Dec 2019421
Jan 2020611
Feb 20201002
Mar 2020843
Apr 2020223
May 2020313
Jun 2020600
Jul 2020200
Aug 2020841
Sep 2020944
Oct 20201922
Nov 20202644
Dec 2020503
Jan 2021845
Feb 202151015
Mar 20213112
Apr 20215158
May 20214142
Jun 20211910
Jul 20211166
Aug 20214129
Sep 20211239
Oct 202122426
Nov 20216915
Dec 20211214
Jan 20223157
Feb 20225203
Mar 20220155
Apr 2022174
May 202212510
Jun 20221138
Jul 20220214
Aug 20221142
Sep 20220227
Oct 20220126
Nov 2022264
Dec 2022351
Jan 202332721
Feb 20233167
Mar 20233396
Apr 20233184
May 20233135
Jun 20230156
Jul 20230185
Aug 20230710
Sep 2023233
Oct 20230103
Nov 2023173
Dec 20231254
Jan 20240243
Feb 20240121
Mar 20241519
Apr 20241239
May 202415113
Jun 20243183
Jul 202423515
Aug 202422420
Sep 202402219
Oct 202472511
Nov 20240156
Dec 20240296
Jan 20251107
Feb 20250567
Mar 202504117
Apr 202555021
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 51 (12)
Journal of Nuclear Medicine
Vol. 51, Issue 12
December 1, 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan or 131I-Tositumomab
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan or 131I-Tositumomab
Sébastien Baechler, Robert F. Hobbs, Heather A. Jacene, François O. Bochud, Richard L. Wahl, George Sgouros
Journal of Nuclear Medicine Dec 2010, 51 (12) 1878-1884; DOI: 10.2967/jnumed.110.079947

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan or 131I-Tositumomab
Sébastien Baechler, Robert F. Hobbs, Heather A. Jacene, François O. Bochud, Richard L. Wahl, George Sgouros
Journal of Nuclear Medicine Dec 2010, 51 (12) 1878-1884; DOI: 10.2967/jnumed.110.079947
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
  • A Compartmental Model of Mouse Thrombopoiesis and Erythropoiesis to Predict Bone Marrow Toxicity After Internal Irradiation
  • Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer
  • Imaging a functional tumorigenic biomarker in the transformed epithelium
  • Radioimmunotherapy with Radretumab in Patients with Relapsed Hematologic Malignancies
  • Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 Imaging
  • RADAR Commentary: Evolution and Current Status of Dosimetry in Nuclear Medicine
  • Google Scholar

More in this TOC Section

  • [18F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
  • Whole-Body [18F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
  • Clinical Outcomes of 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire